All patients had LVEF ≤35% (mean, about 26%) despite optimal medical therapy. Patients were randomized to EECP plus optimal pharmacologic therapy for 7 weeks (n = 93) or optimal pharmacologic ...

EECP appears safe when applied as adjunct therapy for heart failure. The efficacy results of this study must be viewed with care, as the size of the study population was small and comparisons were ...